Search research articles
Contact Us
Filters
Showing results (1071-1080 of 1,101) with videos related to
Page
of 111
Sort By:
Nature
|
May 18, 2018
Bystander CD8<sup>+</sup> T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni, Etienne Becht, Michael Fehlings, et al.
The New England Journal of Medicine
|
September 3, 2020
Capmatinib in <i>MET</i> Exon 14-Mutated or <i>MET</i>-Amplified Non-Small-Cell Lung Cancer
Jürgen Wolf, Takashi Seto, Ji-Youn Han, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 17, 2020
High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint Blockade
Kevin L M Chua, Michael Fehlings, Eugenia L L Yeo, et al.
The British Journal of Dermatology
|
October 2, 2020
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial
K S Thomas, J M Batchelor, P Akram, et al.
JCO Precision Oncology
|
July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience
Amanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2026
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer
Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano, et al.
Immunity
|
December 18, 2016
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency
Yannick Simoni, Michael Fehlings, Henrik N Kløverpris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2017
A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone
L Wang, S M Dehm, D W Hillman, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 6, 2024
China Initiative for Multi-Domain Intervention (CHINA-IN-MUDI) to Prevent Cognitive Decline: Study Design and Progress
S-Y Li, X-Y Xie, D Liu, et al.
The Lancet. Oncology
|
December 16, 2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials
Alexander Drilon, Salvatore Siena, Rafal Dziadziuszko, et al.
Page
of 111
Search research articles
Search
Showing results (1071-1080 of 1,101) with videos related to
Sort By:
Page
of 111
Nature
|
May 18, 2018
Bystander CD8<sup>+</sup> T cells are abundant and phenotypically distinct in human tumour infiltrates
Yannick Simoni, Etienne Becht, Michael Fehlings, et al.
The New England Journal of Medicine
|
September 3, 2020
Capmatinib in <i>MET</i> Exon 14-Mutated or <i>MET</i>-Amplified Non-Small-Cell Lung Cancer
Jürgen Wolf, Takashi Seto, Ji-Youn Han, et al.
International Journal of Radiation Oncology, Biology, Physics
|
June 17, 2020
High-Dimensional Characterization of the Systemic Immune Landscape Informs on Synergism Between Radiation Therapy and Immune Checkpoint Blockade
Kevin L M Chua, Michael Fehlings, Eugenia L L Yeo, et al.
The British Journal of Dermatology
|
October 2, 2020
Randomized controlled trial of topical corticosteroid and home-based narrowband ultraviolet B for active and limited vitiligo: results of the HI-Light Vitiligo Trial
K S Thomas, J M Batchelor, P Akram, et al.
JCO Precision Oncology
|
July 12, 2021
Individualized Molecular Profiling for Allocation to Clinical Trials Singapore Study-An Asian Tertiary Cancer Center Experience
Amanda O L Seet, Aaron C Tan, Tira J Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 26, 2026
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer
Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano, et al.
Immunity
|
December 18, 2016
Human Innate Lymphoid Cell Subsets Possess Tissue-Type Based Heterogeneity in Phenotype and Frequency
Yannick Simoni, Michael Fehlings, Henrik N Kløverpris, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 26, 2017
A prospective genome-wide study of prostate cancer metastases reveals association of wnt pathway activation and increased cell cycle proliferation with primary resistance to abiraterone acetate-prednisone
L Wang, S M Dehm, D W Hillman, et al.
The Journal of Prevention of Alzheimer'S Disease
|
May 6, 2024
China Initiative for Multi-Domain Intervention (CHINA-IN-MUDI) to Prevent Cognitive Decline: Study Design and Progress
S-Y Li, X-Y Xie, D Liu, et al.
The Lancet. Oncology
|
December 16, 2019
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1-2 trials
Alexander Drilon, Salvatore Siena, Rafal Dziadziuszko, et al.
Page
of 111